PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-13.71%
Negative net income growth while EQT stands at 86.71%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
17.57%
Some D&A expansion while EQT is negative at -0.72%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
80.68%
Lower deferred tax growth vs. EQT's 433.22%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
No Data
No Data available this quarter, please select a different quarter.
-720.43%
Negative yoy working capital usage while EQT is 5.70%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-162.94%
Both negative yoy, with EQT at -2807.15%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-45.29%
Both yoy CFO lines are negative, with EQT at -82.91%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
21.44%
Some CapEx rise while EQT is negative at -24.52%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-641.12%
Both yoy lines negative, with EQT at -23.49%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-226.89%
Both yoy lines negative, with EQT at -25.20%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-2582.77%
We cut debt repayment yoy while EQT is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-61.20%
Negative yoy issuance while EQT is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
94.45%
We have some buyback growth while EQT is negative at -221.43%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.